Colonial Trust’s Globus Medical GMED Stock Holding History

Colonial Trust’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.47K	Buy	120 +50	+71%	+$4.25K	﹤0.01%	777
2026 Q1	$5.85K	Hold	70	–	–	﹤0.01%	829
2025 Q4	$6.11K	Sell	70 -35	-33%	-$2.66K	﹤0.01%	825
2025 Q3	$6.01K	Buy	105 +41	+64%	+$2.36K	﹤0.01%	808
2025 Q2	$3.75K	Hold	64	–	–	﹤0.01%	884
2025 Q1	$4.64K	Hold	64	–	–	﹤0.01%	837
2024 Q4	$5.29K	Hold	64	–	–	﹤0.01%	1057
2024 Q3	$4.52K	Hold	64	–	–	﹤0.01%	890
2024 Q2	$4.41K	Hold	64	–	–	﹤0.01%	862
2024 Q1	$3.4K	Buy	64 +17	+36%	+$914	﹤0.01%	874
2023 Q4	$2.54K	Hold	47	–	–	﹤0.01%	877
2023 Q3	$2.43K	Hold	47	–	–	﹤0.01%	876
2023 Q2	$2.77K	Hold	47	–	–	﹤0.01%	859
2023 Q1	$2.62K	Hold	47	–	–	﹤0.01%	824
2022 Q4	$3.5K	Buy	+47	New	+$3.2K	﹤0.01%	799

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Colonial Trust's GMED Position: Q2 2026 in Review

Colonial Trust increased its Globus Medical (GMED) stake by 71% in Q2 2026, buying an estimated $4.25K and bringing the position to 120 shares worth $9.47K. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Colonial Trust first reported a position in GMED in Q4 2022 and has held it in 15 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Colonial Trust held 120 shares of Globus Medical worth $9.47K as of Q2 2026.
Colonial Trust bought 50 Globus Medical shares in Q2 2026, an estimated $4.25K.
Globus Medical made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #777 holding.
Colonial Trust first reported a position in Globus Medical in Q4 2022 and has held it in 15 quarters since.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.